These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 15460561)

  • 41. Biomedical research and the commercialization agenda: a review of main considerations for neuroscience.
    Caulfield T; Ogbogu U
    Account Res; 2008; 15(4):303-20. PubMed ID: 18972268
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Federal funding of human embryonic stem cell research: an institutional examination.
    Fujikawa R
    South Calif Law Rev; 2005 May; 78(4):1075-124. PubMed ID: 17340756
    [No Abstract]   [Full Text] [Related]  

  • 43. Stem cell research in California: the game is on.
    Trounson A; Klein R; Murphy R
    Cell; 2008 Feb; 132(4):522-4. PubMed ID: 18295567
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Moving human embryonic stem cells from legislature to lab: remaining legal and ethical questions.
    Greely HT
    PLoS Med; 2006 Feb; 3(5):e143. PubMed ID: 16492089
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Research on human embryos, stem cells and cloning -- one year since the passing of Australian federal legislation: Australia around the world and back again.
    Magri S
    E Law; 2003 Dec; 10(4):E7. PubMed ID: 16903024
    [No Abstract]   [Full Text] [Related]  

  • 46. Stem cell research: science, ethics and policy.
    Daley GQ; Sandel MJ; Moreno JD
    Med Ethics (Burlingt Mass); 2005; 12(1):5. PubMed ID: 15856604
    [No Abstract]   [Full Text] [Related]  

  • 47. The paper trail to commercialization.
    Kling J; DeFrancesco L
    Nat Biotechnol; 2007 Nov; 25(11):1217-23. PubMed ID: 17989671
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Stem cell lines. Regulations constrain stem cell research across the globe.
    Vogel G
    Science; 2002 Aug; 297(5583):924. PubMed ID: 12169709
    [No Abstract]   [Full Text] [Related]  

  • 49. A venture capital view of challenges, opportunities, and innovation in biomedical research.
    Ratcliffe LT
    Clin Pharmacol Ther; 2011 Feb; 89(2):174-6. PubMed ID: 21252935
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hwang scandal hits Korean biotech hard.
    Fuyuno I
    Nature; 2006 Jan; 439(7074):265. PubMed ID: 16421542
    [No Abstract]   [Full Text] [Related]  

  • 51. California makes unprecedented commitment to fund stem cell research.
    Willard LA
    J Biolaw Bus; 2005; 8(2):47-8. PubMed ID: 16538814
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Patent rights and the free research. The boundary between basic research and private sector is not longer razor-sharp].
    Westerlund L
    Lakartidningen; 2005 Sep 26-Oct 2; 102(39):2737. PubMed ID: 16245544
    [No Abstract]   [Full Text] [Related]  

  • 53. The dilemmas of German bioethics.
    Brown E
    New Atlantis; 2004; 5():37-53. PubMed ID: 15586957
    [No Abstract]   [Full Text] [Related]  

  • 54. Senators mull new ways to make stem cells.
    Regalado A
    Wall St J (East Ed); 2005 Jul; ():B1,B4. PubMed ID: 16134272
    [No Abstract]   [Full Text] [Related]  

  • 55. State stem cell initiatives. Most state stem cell efforts staying afloat.
    Holden C
    Science; 2009 Mar; 323(5922):1660-1. PubMed ID: 19325092
    [No Abstract]   [Full Text] [Related]  

  • 56. Navigating the quagmire: the regulation of human embryonic stem cell research.
    Jones DG; Towns CR
    Hum Reprod; 2006 May; 21(5):1113-6. PubMed ID: 16361280
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Leaders and laggards in the stem cell enterprise.
    Herrera S
    Nat Biotechnol; 2005 Jul; 23(7):775-7. PubMed ID: 16003350
    [No Abstract]   [Full Text] [Related]  

  • 58. Stem cells, politics and the progress paradigm.
    DeBow S; Bubela T; Caulfield T
    Health Law Rev; 2006; 15(1):50-2. PubMed ID: 17153769
    [No Abstract]   [Full Text] [Related]  

  • 59. Market entry and exit by biotech and device companies funded by venture capital.
    Burns LR; Housman MG; Robinson CA
    Health Aff (Millwood); 2009; 28(1):w76-86. PubMed ID: 19049998
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Australia. Stem cell center looks to recast itself in supporting role.
    Finkel E
    Science; 2009 Mar; 323(5921):1552-3. PubMed ID: 19299596
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.